Performance for each region and pathway

Summary

This page shows the percentages of patients within waiting times standards, by Cancer Alliance and pathway.

Time period of data: October 2023 to February 2025

28-day Faster Diagnosis Standard

Figure 1: 28-day Faster Diagnosis Standard - Percentage of patients within standard (and 95% confidence intervals), by Cancer Alliance and pathway. The dashed line at 80% indicates the national objective.

31-day treatment standard

By cancer type

Figure 2: 31-day treatment standard - Percentage of patients within standard, by Cancer Alliance and cancer type for first treatments. The dashed line at 96% indicates the national objective.
Figure 3: 31-day treatment standard - Percentage of patients within standard, by Cancer Alliance and cancer type for subsequent treatments. The dashed line at 96% indicates the national objective.

By treatment modality

Figure 4: 31-day treatment standard - Percentage of patients within standard, by Cancer Alliance, treatment modality, and first or subsequent treatment. The dashed line at 96% indicates the national objective.

62-day treatment standard

By cancer type

Figure 5: 62-day treatment standard - Percentage of patients within standard, by Cancer Alliance and cancer type for urgent suspected cancer referrals. The dashed line at 85% indicates the national objective.
Figure 6: 62-day treatment standard - Percentage of patients within standard, by Cancer Alliance and cancer type for consultant upgrade referrals. The dashed line at 85% indicates the national objective.
Figure 7: 62-day treatment standard - Percentage of patients within standard, by Cancer Alliance and cancer type for screening referrals. The dashed line at 85% indicates the national objective.

By treatment modality

Figure 8: 62-day treatment standard - Percentage of patients within standard, by Cancer Alliance, treatment modality, and referral pathway. The dashed line at 85% indicates the national objective.